Zu "1337531-36-8" wurden 3 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
GSK2606414
Artikelnummer: TGM-T2614-10mg
Description: GSK2606414 is an oral-available and specific PERK inhibitor (IC50=0.4 nM). Target: Apoptosis, PERK, Autophagy. Smiles: NC1=C2C(=CN(C)C2=NC=N1)C=3C=C4C(=CC3)N(C(CC5=CC(C(F)(F)F)=CC=C5)=O)CC4. References: Axten JM, et al. J Med Chem. 2012, 55(16), 7193-7207.
| Anwendung: | EIF2AK3?/ PERK inhibitor |
| CAS | 1337531-36-8 |
| MW: | 451.44 D |
ab 60,00 €
GSK2606414
Artikelnummer: Cay17376-1
GSK2606414 is an orally available, selective protein kinase R-like ER kinase (PERK) inhibitor with an IC50 value of 0.4 nM. It can inhibit thapsigargin-induced PERK phosphorylation in lung carcinoma A549 cells and attenuates subcutaneous pancreatic human tumor xenograft growth in mice. Because PERK mediates the...
| Schlagworte: | 1-[5-(4-amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2,3-dihydro-1H-indol-1-yl]-2-[3-(trifluoromethyl)phenyl]-ethanone |
| Anwendung: | EIF2AK3?/ PERK inhibitor |
| CAS | 1337531-36-8 |
| MW: | 451.4 D |
ab 49,00 €
GSK-2606414
Artikelnummer: SYN-1201-M001
Soluble in DMSO or ethanol. GSK2606414 is an orally available, potent, and selective PERK inhibitor with IC(50) of 0.4nM, displaying at least 100-fold selectivity over the other EIF2AKs assayed Target: PERK , Kinase Group: Other , Substrate: Serine-Threonine
| Schlagworte: | GSK-2606414 |
| Anwendung: | EIF2AK3 / PERK inhibitor |
| CAS | 1337531-36-8 |
| MW: | 451,4 D |
ab 139,00 €
